R&D Views & Analysis | pharmaphorum

Thursday 23 July 2026

Views & Analysis

Views & Analysis

3d illustration and concept of international logistics of agreements and international business. Networks and companies around the world

Time for a health innovation pact: rethinking the design and...

Janssen’s Anouk De Vroey on why we need to extend the public/private partnerships resulting from COVID-19 into more high-level dialogue on health innovation with governments.

Oncology

cancer_cells

Sharing oncology trial PROs to build the treatment of the fu...

Could collecting, understanding, and disseminating patient-reported outcomes during trials be the key to advancing oncology treatments and improving cancer outcomes?

Views & Analysis

Coronavirus pharma news roundup

Coronavirus pharma news round-up 21/08/20

New insights into smell and taste loss symptoms, artificial intelligence and further encouraging data from a vaccine candidate hit the headlines this week as the COVID-19 coronavirus pandem

Views & Analysis

Covid-19 Wearing mask in an airport departure lounge

Coronavirus pharma news roundup – 14/08/20

Catch up on the latest coronavirus vaccine and digital tech news in our roundup of this week’s biggest stories.

Views & Analysis

Coronavirus pharma news roundup

Coronavirus pharma news roundup - 07/08/20

Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales.

Views & Analysis

London, January 26, 2020. People wearing a face masks to protecting themself because of epidemic in China. Selective Focus. Concept of coronavirus quarantine. MERS-Cov, middle East respiratory syndrome coronavirus, Novel coronavirus 2019-nCoV.

Coronavirus pharma news roundup – 31/07/20

Vaccines, AI-driven drug discovery and llamas all hit the headlines this week as the search for a way to end the COVID-19 pandemic continues.